As a drug company you would manufacture it. Charge less for it than what others are charging.
If the price of insulin is as outrageous as the article claims, that’d be easy to do.
If not, then it is priced correctly.
“that’d be easy to do.”
Breaking into the $300 billion/year federally-regulated drug maker country club isn’t easy.
Bureaucrats fear risk. Newcomers are risky.
The US Patent Office is a monopoly.
The FDA is a monopoly.
‘No’ is always the safe bureaucratic answer.
Are you the patent holder of this insulin, or are you talking about others simply copying the formula?
Even still, insulin manufacturing is a very complex process. It takes well over two months just to grow and make the API (active pharmaceutical ingredient.) It involves lots of customized lab equipment. You then have to aseptically make that into a solution and fill it into vials or pens, however you plan to deliver this to patients.
I would also remind you that insulin should typically be kept under refrigeration, in order to preserve its stability. That adds to the cost or both storage and distribution.
How much do you think you could sell a 10mL vial for, with all of those considerations? Could you be competitive and still make a profit?